Cambridge Investment Research Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.68M Sell
7,965
-2,855
-26% -$612K ﹤0.01% 1826
2026
Q1
$2.39M Buy
10,820
+63
+0.6% +$15.4K 0.01% 1464
2025
Q4
$2.73M Buy
10,757
+382
+4% +$95.9K 0.01% 1290
2025
Q3
$2.57M Buy
10,375
+941
+10% +$225K 0.01% 1318
2025
Q2
$2.27M Buy
9,434
+483
+5% +$112K 0.01% 1341
2025
Q1
$2.03M Buy
8,951
+431
+5% +$94.8K 0.01% 1332
2024
Q4
$1.75M Buy
8,520
+1,115
+15% +$245K 0.01% 1454
2024
Q3
$1.8M Sell
7,405
-121
-2% -$28.3K 0.01% 1428
2024
Q2
$1.65M Sell
7,526
-95
-1% -$20.6K 0.01% 1426
2024
Q1
$1.71M Buy
7,621
+234
+3% +$52.8K 0.01% 1368
2023
Q4
$1.62M Sell
7,387
-150
-2% -$31.7K 0.01% 1335
2023
Q3
$1.65M Buy
7,537
+220
+3% +$49.8K 0.01% 1259
2023
Q2
$1.65M Buy
7,317
+311
+4% +$62.2K 0.01% 1288
2023
Q1
$1.34M Sell
7,006
-1,230
-15% -$238K 0.01% 1376
2022
Q4
$1.52M Buy
8,236
+639
+8% +$112K 0.01% 1247
2022
Q3
$1.26M Buy
7,597
+568
+8% +$116K 0.01% 1325
2022
Q2
$1.45M Sell
7,029
-278
-4% -$62.7K 0.01% 1216
2022
Q1
$1.77M Sell
7,307
-6
-0.1% -$1.39K 0.01% 1212
2021
Q4
$1.78M Buy
7,313
+295
+4% +$67.4K 0.01% 1214
2021
Q3
$1.43M Sell
7,018
-71
-1% -$15.2K 0.01% 1279
2021
Q2
$1.46M Buy
+7,089
New +$1.43M 0.01% 1289
2021
Q1
Sell
-5,088
Closed -$964K 2982
2020
Q4
$964K Sell
5,088
-45
-0.9% -$8.4K 0.01% 1329
2020
Q3
$904K Buy
5,133
+104
+2% +$16.6K 0.01% 1247
2020
Q2
$772K Buy
5,029
+741
+17% +$113K 0.01% 1287
2020
Q1
$600K Buy
4,288
+2,708
+171% +$405K 0.01% 1264
2019
Q4
$241K Buy
1,580
+190
+14% +$27.8K ﹤0.01% 2076
2019
Q3
$201K Buy
+1,390
New +$208K ﹤0.01% 2123

Other funds holding STE

Cambridge Investment Research Advisors's STE Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Steris (STE) stake by 26% in Q2 2026, selling an estimated $612K and leaving 7,965 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1826.

Cambridge Investment Research Advisors first reported a position in STE in Q3 2019 and has held it in 27 quarters since. The position peaked at $2.73M in Q4 2025. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Cambridge Investment Research Advisors held 7,965 shares of Steris worth $1.68M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 2,855 Steris shares in Q2 2026, an estimated $612K.
  • Steris made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1826 holding.
  • Cambridge Investment Research Advisors first reported a position in Steris in Q3 2019 and has held it in 27 quarters since.
  • Cambridge Investment Research Advisors's Steris position peaked at $2.73M in Q4 2025.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.